0.000USD0.000盘前交易 07/24, 09:30 (美东)
关键数据
310.000今开
319.380最高
2.51M成交量
36.58市盈率 TTM
18.86市盈率动
3.440股息TTM
0.66%换手率
309.240昨收
306.900最低
442.08M成交额
40.79市盈率静
5.45市净率
1.08%股息率 TTM
7.23%ROA
404.87052周最高
1.26量比
2.99B净利润
382.50M总股本
8.7252每股收益TTM
0.79Beta
15.20%ROE
281.00052周最低
4.04%振幅
60.58%毛利率
122.10B总市值
-1.02回报/风险
1.38%风险率
操作建议
史赛克当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名15/200位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价387.46。中期看,股价处于平稳状态。近一个月,市场表现一般,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
收益预测
Zimmer Biomet Holdings Inc
ZBH
31
Medline Ord Shs Class A
MDLN
28
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
史赛克简介
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
公司代码SYK
公司史赛克
CEOLobo (Kevin A)
网址https://www.stryker.com/
公司股东
常见问题
现在史赛克(SYK)的股票是买入、持有还是卖出?
根据分析师评级,史赛克(SYK)的总体评级为买入,目标价格为387.46。
史赛克(SYK)股票的每股收益(EPS TTM)是多少
史赛克(SYK)股票的每股收益(EPS TTM)是8.49。